Hydrocortisone suppression of the fear-potentiated startle response and posttraumatic stress disorder

Psychoneuroendocrinology. 2011 Aug;36(7):970-80. doi: 10.1016/j.psyneuen.2010.12.009. Epub 2011 Jan 26.

Abstract

This study examined the effects of oral administration of 20mg hydrocortisone on baseline and fear-potentiated startle in 63 male veterans with or without PTSD. The procedure was based on a two-session, within-subject design in which acoustic startle eyeblink responses were recorded during intervals of threat or no threat of electric shock. Results showed that the magnitude of the difference between startle responses recorded during anticipation of imminent shock compared to "safe" periods was reduced after hydrocortisone administration relative to placebo. This effect did not vary as a function of PTSD group nor were there were any significant group differences in other indices startle amplitude. Findings suggest that the acute elevations in systemic cortisol produced by hydrocortisone administration may have fear-inhibiting effects. This finding may have implications for understanding the role of hypothalamic-pituitary-adrenal (HPA)-axis function in vulnerability and resilience to traumatic stress.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Affect / drug effects
  • Anxiety / epidemiology
  • Blinking / drug effects
  • Blinking / physiology
  • Double-Blind Method
  • Down-Regulation / drug effects
  • Fear / drug effects*
  • Fear / physiology
  • Humans
  • Hydrocortisone / administration & dosage
  • Hydrocortisone / adverse effects
  • Hydrocortisone / pharmacology*
  • Male
  • Middle Aged
  • Placebos
  • Reflex, Startle / drug effects*
  • Reflex, Startle / physiology
  • Self-Assessment
  • Stress Disorders, Post-Traumatic / drug therapy
  • Stress Disorders, Post-Traumatic / epidemiology
  • Stress Disorders, Post-Traumatic / physiopathology*
  • Young Adult

Substances

  • Placebos
  • Hydrocortisone